References
- Shi L. Isolation, purification, and immunomodulatory activity in vitro of three polysaccharides from roots of Cudrania tricuspidata. Acta Biochim Biophys Sin (Shanghai). 2011;43(5):418-24. https://doi.org/10.1093/abbs/gmr024 PMid:21467071
- Sülsen VP, Martino VS. Sesquiterpene Lactones: Advances in their Chemistry and Biological Aspects. Germany: Springer; 2018. p. 371.
- Merfort I. Perspectives on sesquiterpene lactones in inflammation and cancer. Curr Drug Targets. 2011;12(11):1560-73. https://doi.org/10.2174/138945011798109437 PMid:21561425
- Peterková L, Rimpelová S, Kmoníčková E, Ruml T. Sesquiterpene lactones: From weed to remedy (Seskviterpenové laktony: Od plevelu k léčivu. J Chem Listy. 2019;113(3):149-55.
- Harmatha J, Buděšinsky M, Vokač K, Kmoničkova E, Zidek Z. Targeted modification of trilobolide and search for related sesquiterpenes with immunobiological properties. Planta Med. 2011;77:PM3. https://doi.org/10.1055/s-0031-1282761
- Harmathaa J, Buděšinsky M, Jurašekb M, Zimmermannb T, Drašarb P, Zidekc Z, et al. Structural modification of trilobolide for upgrading its immunobiological properties and reducing its cytotoxic action. Fitoterapia. 2019;134:88-95. https://doi.org/10.1016/j.fitote.2019.02.002 PMid:30731148
- Harmatha J, Buděšínský M, Vokáč K, Kostecká P, Kmoníčková E, Zídek Z. Trilobolide and related sesquiterpene lactones from Laser trilobum possessing immunobiological properties. Fitoterapia. 2013;89:157-66. https://doi.org/10.1016/j.fitote.2013.05.025 PMid:23747321
- Harmatha J, Vokáč K, Buděšínský M, Zídek Z, Kmoníčková E. Immunobiological properties of sesquiterpene lactones obtained by chemically transformed structural modifications of trilobolide. Fitoterapia. 2015;107:90-9. https://doi.org/10.1016/j.fitote.2015.10.002 PMid:26474674
- Kmonickova E, Rimpelova S, Jurasek M, Dzubak P, Sedlak D, Zidek Z, et al. Pharmacological Activities Of Sesquiterpene Lactone Trilobolide And Its Conjugates As a Promising Compounds For Anticancer And Immunomodulatory Therapies. Article in Proceedings for Annual Meeting of the Japanese Pharmacological Society; 2018. https://doi.org/10.1254/jpssuppl.WCP2018.0_OR34-3
- Mironov AN. Guidelines for Conducting Preclinical Studies of Drugs. Part one/M Grif and K. Moskow: 2012. p. 944.
- Guidelines for the Experimental (Preclinical) Study of New Pharmacological Substances. Under the General Editorship of Corresponding Member of the Russian Academy of Medical Sciences, Professor R.U. Khabriev. 2nd ed. Moscow: Medicine; 2005. p. 637.
- Lyb G, Schmidt TJ, Pahl HL, Merfort I. Anti-inflammatory activity of Arnica tincture (DAB 1998) using the transcription factor NF-KB as molecular target. Pharm Pharmacol Lett. 1999;9(1):5-8.
- Mozaffari F, Lindemalm C, Choudhury A, Granstam-Bjorneklett H, Helander I, Lekander M, et al. NK-cell and T-cell functions in patients with breast cancer: Effects of surgery and adjuvant chemo-and radiotherapy. Br J Cancer. 2007;97:105-11. https://doi.org/10.1038/sj.bjc.6603840 PMid:17551492
- Orange SJ, Balias KZ. Natural killer cells in human health and disease. Clin Immunol. 2006;118(1):1-10. https://doi.org/10.1016/j.clim.2005.10.011 PMid:16337194
- Jia QQ, Wang JC, Long J, Zhao Y, Chen SJ, Zhai JD, et al. Sesquiterpene lactones and their derivatives inhibit high glucose-induced NF-kB activation and MCP-1 and TGF-β1 expression in rat mesangial cells. Molecules. 2013;18(10):13061-77. https://doi.org/10.3390/molecules181013061 PMid:24152676
- Mammesier E, Aude S, Olive D. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Investig. 2011;121(9):3609-22. https://doi.org/10.1172/JCI45816 PMid:21841316
- Issacs JT. New strageties for the medical treatment of prostate cancer. BJU Internat. 2010;96(Suppl 2):35-40. https://doi.org/10.1111/j.1464-410X.2005.05945.x PMid:16359437
- Curry EA 3rd, Murry DJ, Yoder C, Fife K, Armstrong V, Nakshatri H, et al. Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer. Invest New Drugs. 2004;22(3):299-305. https://doi.org/10.1023/B: DRUG.0000026256.38560.be PMid:15122077
- Picmann AK. Biological activities of sesquiterpene lactones. Biochem Systemat Ecol. 1986;14(3):255-81. https://doi.org/10.1016/0305-1978(86)90101-8
- Koch E, Klaas CA, Rungeler P, Castro V, Mora G, Vichnewski W, et al. Inhibition of inflammatory cytokine production and lymphocyte proliferation by structurally different sesquiterpene lactones correlates with their effect on activation of NF-kappaB. Biochem Pharmacol. 2001;62(6):795-801. https://doi.org/10.1016/s0006-2952(01)00714-6 PMid:11551526
- Dirsch VM, Stuppner H, Ellmerer-Muller EP, Vollmar AM. Structural requirements of sesquiterpene lactones to inhibit LPS-induced nitric oxide synthesis in RAW 264.7 macrophages. Bioorg Med Chem. 2000;8(12):2747-53. https://doi.org/10.1016/s0968-0896(00)00202-9 PMid:11131166